Tempus AI (NASDAQ:TEM) Shares Gap Up – What’s Next?

Tempus AI, Inc. (NASDAQ:TEM) gapped up before the market opened on Wednesday . The stock had previously closed at $45.58, but opened at $48.75. Tempus AI shares last traded at $45.68, with a volume of 3,267,094 shares changing hands.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on TEM shares. Loop Capital reduced their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, January 14th. William Blair reiterated a “market perform” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Needham & Company LLC increased their target price on Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a research report on Tuesday, February 25th. Bank of America lifted their price target on Tempus AI from $54.00 to $60.00 and gave the company a “neutral” rating in a research report on Monday, March 3rd. Finally, Piper Sandler cut their price objective on shares of Tempus AI from $70.00 to $55.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Tempus AI presently has a consensus rating of “Moderate Buy” and a consensus target price of $61.18.

Tempus AI Price Performance

The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The business has a fifty day moving average price of $55.00 and a 200-day moving average price of $51.98.

Insider Activity

In other Tempus AI news, major shareholder Bradley A. Keywell sold 265,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were sold at an average price of $35.10, for a total value of $9,301,500.00. Following the sale, the insider now owns 15,218,365 shares of the company’s stock, valued at $534,164,611.50. This trade represents a 1.71 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Eric P. Lefkofsky sold 562,345 shares of Tempus AI stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $50.93, for a total transaction of $28,640,230.85. Following the completion of the sale, the chief executive officer now owns 9,457,283 shares in the company, valued at approximately $481,659,423.19. This trade represents a 5.61 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 5,755,906 shares of company stock valued at $322,788,693.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Operose Advisors LLC bought a new stake in shares of Tempus AI during the 4th quarter valued at about $25,000. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI during the 3rd quarter valued at $30,000. Farther Finance Advisors LLC purchased a new stake in shares of Tempus AI in the 4th quarter worth $34,000. Prestige Wealth Management Group LLC increased its stake in shares of Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after purchasing an additional 965 shares in the last quarter. Finally, NewEdge Advisors LLC purchased a new position in Tempus AI during the fourth quarter valued at $49,000. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.